Ledger.Open graph →
SEC Form D · filed March 1, 2024

RYNE Biotechnology Inc

Offering
$81.8M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Howard Federoff · Cambridge, MAExec · DirectorJonathan Yeh · Cambridge, MADirectorNick Manusos · Cambridge, MAExec · DirectorDean Mai · Los Angeles, CAExec · DirectorDavis Treybig · Los Angeles, CAExec · DirectorIgnacio Novoa · Brea, CADirectorJeff Goater · Cambridge, MADirectorPeter Fuhrken · Cambridge, MADirectorDavid Fallace · Cambridge, MADirectorJeff Jonas · Cambridge, MADirectorMartin Ostrowski · Cambridge, MAExecSpencer Hart · Dallas, TXExec · DirectorRyan Waddington · A, MIDirectorSusan V. Dinges · HOUSTON, TXExec · DirectorJeff Goater · Cambridge, MADirectorPeter Fuhrken · Cambridge, MADirectorDavid Fallace · Cambridge, MADirectorJeff Jonas · Cambridge, MADirectorMartin Ostrowski · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗